
Amrit Kaushal
About Amrit Kaushal
Data last updated:
Amrit Kaushal is a Director at Concur Pharmaceuticals Private Limited (since 2012) and Managing Director at Daikon Pharmaceuticals Private Limited (since 2018). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹16.47 Cr; the largest is Concur Pharmaceuticals Private Limited at ₹9.98 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jan 2012 | 2011 | ₹9.98 Cr (FY 2024) | Active | |
| Managing Director | 08 Mar 2018 | 2018 | ₹6.49 Cr (FY 2025) | Active |
Board colleagues of Amrit Kaushal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajeet Kumar | 03376763 | Concur Pharmaceuticals Private Limited | Director |
| Patanjali Kumar | 05182576 | Concur Pharmaceuticals Private Limited | Director |
| Ravi Shankar Choudhary | 05217897 | Concur Pharmaceuticals Private Limited | Director |
| Sandip Hazari | 05218370 | Concur Pharmaceuticals Private Limited | Director |
| Menka Kumari | 08081477 | Daikon Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amrit Kaushal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amrit Kaushal
Amrit Kaushal currently holds 2 directorships: Concur Pharmaceuticals Private Limited (Director, since 16 Jan 2012, revenue ₹9.98 Cr (FY 2024)); Daikon Pharmaceuticals Private Limited (Managing Director, since 08 Mar 2018, revenue ₹6.49 Cr (FY 2025)).
Amrit Kaushal was first appointed on 16 Jan 2012 as Director at Concur Pharmaceuticals Private Limited. The most recent appointment on record is 08 Mar 2018 at Daikon Pharmaceuticals Private Limited.
The 2 current companies of Amrit Kaushal that report revenue have a combined latest revenue of ₹16.47 Cr: Concur Pharmaceuticals Private Limited ₹9.98 Cr (FY 2024); Daikon Pharmaceuticals Private Limited ₹6.49 Cr (FY 2025).
The current boards of Amrit Kaushal's companies include Ajeet Kumar (Concur Pharmaceuticals Private Limited), Patanjali Kumar (Concur Pharmaceuticals Private Limited), Ravi Shankar Choudhary (Concur Pharmaceuticals Private Limited), Sandip Hazari (Concur Pharmaceuticals Private Limited), Menka Kumari (Daikon Pharmaceuticals Private Limited).